CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
CAMP4 Therapeutics has raised $30.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
CAMP4 Therapeutics's investors include Andreessen Horowitz, Gaingels, Vivo Capital, Janus Henderson Investors, Balyasny Asset Management.
CAMP4 Therapeutics is headquartered in Cambridge, United States.
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
CAMP4 Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CAMP4 Therapeutics — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/camp4-therapeutics. Accessed July 20, 2026.
VCBacked. (2025). CAMP4 Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/camp4-therapeutics
{{cite web |title=CAMP4 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/camp4-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated